Oracle Investment Management as of March 31, 2017
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 18 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 34.9 | $211M | 1.4M | 153.87 | |
| Mazor Robotics Ltd. equities | 13.3 | $81M | 2.7M | 29.77 | |
| NxStage Medical | 12.5 | $76M | 2.8M | 26.83 | |
| Quidel Corporation | 9.4 | $57M | 2.5M | 22.64 | |
| Pacific Biosciences of California (PACB) | 4.7 | $29M | 5.5M | 5.17 | |
| Opko Health (OPK) | 4.7 | $28M | 3.5M | 8.00 | |
| Accelr8 Technology | 3.8 | $23M | 4.8M | 4.75 | |
| Amarin Corporation (AMRN) | 3.6 | $22M | 6.7M | 3.20 | |
| Biolase Technology | 3.3 | $20M | 15M | 1.35 | |
| Vermillion | 3.2 | $19M | 9.2M | 2.09 | |
| Intrexon | 2.3 | $14M | 695k | 19.82 | |
| Epizyme | 1.5 | $8.9M | 517k | 17.15 | |
| Accuray Incorporated (ARAY) | 1.1 | $6.7M | 1.4M | 4.75 | |
| Agenus (AGEN) | 1.1 | $6.4M | 1.7M | 3.77 | |
| Contrafect | 0.3 | $2.1M | 1.2M | 1.80 | |
| Biogen Idec (BIIB) | 0.3 | $1.7M | 6.4k | 273.40 | |
| Aquabounty Technologies | 0.0 | $135k | 12k | 11.06 | |
| Second Sight Med Prods | 0.0 | $61k | 51k | 1.20 |
